Immunome

About:

Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.

Twitter/X: Immunome

Top Investors: BioAdvance, Enavate Sciences, Woodline Partners, U.S. Department of Defense, Redmile Group

Description:

Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery. It features a software platform that enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens.

Total Funding Amount:

$449M

Headquarters Location:

Exton, Pennsylvania, United States

Founded Date:

2008-01-01

Contact Email:

i-info(AT)immunomeinc.com

Founders:

Scott Dessain

Number of Employees:

11-50